Media Newsroom of

HOPE BIOSCIENCES, INC.

United States
Website: http://WWW.HOPEBIOSCI.COM
HOPE BIOSCIENCES, INC.

HOPE BIOSCIENCES, INC. is a privately-owned biopharmaceutical company based in Irvine, California focused on licensing and commercializing anti-cancer drugs that address high unmet medical needs. HOPE has two unique assets currently in IND-enabling studies, including nuc-gemcitabine (HOPE-888), and a highly potent MerTK/AXL kinase inhibitor (HOPE-777).

Hope Biosciences Acquires Worldwide Rights To Novel MERTK/AXL Inhibitor From NeoPharm

HOPE BIOSCIENCES, INC. announced today that it has acquired exclusive and worldwide rights to develop and commercialize HOPE 777, a unique MERTK/AXL/pan-c-MET tyrosine kinase inhibitor through a licensing agreement with NeoPharm Co. Ltd, a South Korean pharmaceutical company. HOPE 777…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login